Simultaneous analytical measurement of multiple protein biomarkers continues to hold promise in the identification of molecular signatures that may impact research applications, ranging from ...

Mass Spec Alternative Detects Biomarker Signatures in Tissues, Blood, and Cell Culture The current generation of antibody microarray technologies is providing highly sensitive new tools for screening ...

AMSBIO has announced the availability of ultraspecific and extensively validated monoclonal antibodies under the UltraMAB™ brand. Screening of candidate antibodies against greater than 10,000 human ...

In an exciting, state-of-the-art study currently available on the medRxiv* preprint server, US researchers created a multi-coronavirus protein microarray containing full-length proteins, peptide ...

Dublin-listed pharmaceutical services company Open Orphan has launched its Covid-19 antibody testing service, supporting the reopening of economies as coronavirus pandemic restrictions ease. The Hvivo ...

Dublin, Jan. 02, 2024 (GLOBE NEWSWIRE) -- The "Blood Group Typing Market by Product (Consumables, Instruments, Services), Test Type (ABO, Antigen, Antibody, HLA), Technique (Assay-based, PCR, ...

For example, it could be used for mapping the fine specificities of other anti-GPI antibodies such as the 'campath antibody' used to treat chronic lymphocytic leukemia, and other GPI-binding proteins ...

OriGene Technologies has announced the release of a new line of ultra specific and extensively validated monoclonal antibodies under the UltraMAB™ brand. UltraMAB Antibodies are a collection of ...

A number of companies are using the lessons and technologies of traditional genomics--the microarray chief among them--to delve into the more challenging world of functional genomics and proteomics.

SHARES in pharma services company Open Orphan jumped more than 11pc in London yesterday after it said a subsidiary will have the capability to undertake "up to 3,000" antibody tests a day within two ...

JERSEY, Channel Islands, May 01, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced ...